Dantrolene inhibition of ryanodine channels (RyR2) in artificial lipid bilayers depends on FKBP12.6
Journal of General Physiology · 2023
DOI: 10.1085/jgp.202213277 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of General Physiology, 2023. Verfasst von Kafa Walweel und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Biomedical Sciences and Pharmacy, University of Newcastle and Hunter Medical Research Institute , Callaghan, Australia. Hauptthemen laut MEDLINE: Ryanodine Receptor Calcium Release Channel, Dantrolene. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0). Gefördert von: NSW Ministry of Health, Hunter Medical Research Institute, National Health and Medical Research Council.
Abstract (Originalsprache)
Dantrolene is a neutral hydantoin that is clinically used as a skeletal muscle relaxant to prevent overactivation of the skeletal muscle calcium release channel (RyR1) in response to volatile anesthetics. Dantrolene has aroused considerable recent interest as a lead compound for stabilizing calcium release due to overactive cardiac calcium release channels (RyR2) in heart failure. Previously, we found that dantrolene produces up to a 45% inhibition RyR2 with an IC50 of 160 nM, and that this inhibition requires the physiological association between RyR2 and CaM. In this study, we tested the hypothesis that dantrolene inhibition of RyR2 in the presence of CaM is modulated by RyR2 phosphorylation at S2808 and S2814. Phosphorylation was altered by incubations with either exogenous phosphatase (PP1) or kinases; PKA to phosphorylate S2808 or endogenous CaMKII to phosphorylate S2814. We found that PKA caused selective dissociation of FKBP12.6 from the RyR2 complex and a loss of dantrolene inhibition. Rapamycin-induced FKBP12.6 dissociation from RyR2 also resulted in the loss of dantrolene inhibition. Subsequent incubations of RyR2 with exogenous FKBP12.6 reinstated dantrolene inhibition. These findings indicate that the inhibitory action of dantrolene on RyR2 depends on RyR2 association with FKBP12.6 in addition to CaM as previously found.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- School of Biomedical Sciences and Pharmacy, University of Newcastle and Hunter Medical Research Institute , Callaghan, Australia.
- Faculty of Science and Technology, University of Canberra, Bruce, Australia.
ORCID-Profile: Kafa Walweel, Nicole Beard, Dirk F van Helden, Derek R Laver
Förderung
- NSW Ministry of Health
- Hunter Medical Research Institute
- National Health and Medical Research Council
Zitieren
APA
Walweel, K., Beard, N., van Helden, D. F., & Laver, D. R. (2023). Dantrolene inhibition of ryanodine channels (RyR2) in artificial lipid bilayers depends on FKBP12.6. Journal of General Physiology. https://doi.org/10.1085/jgp.202213277
Vancouver
Walweel K, Beard N, van Helden DF, Laver DR. Dantrolene inhibition of ryanodine channels (RyR2) in artificial lipid bilayers depends on FKBP12.6. Journal of General Physiology. 2023. doi:10.1085/jgp.202213277
BibTeX
@article{Walweel2023,
author = {Walweel, Kafa and Beard, Nicole and van Helden, Dirk F and Laver, Derek R},
title = {Dantrolene inhibition of ryanodine channels (RyR2) in artificial lipid bilayers depends on FKBP12.6},
journal = {Journal of General Physiology},
year = {2023},
doi = {10.1085/jgp.202213277}
}
EUVIMED